Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.1500 (0.08%) ($6.1500 - $6.1500) on Tue. Aug. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.79% (three month average) | RSI | 31 | Latest Price | $6.1500(0.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(70%) ARKK(67%) IWO(65%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -1.895% in a week (0% probabilities). VIXM(-49%) VXX(-38%) UUP(-15%) TLT(-6%) SHY(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.895% (StdDev 3.79%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.14(-118.54%) | Resistance Level | $6.65 | 5 Day Moving Average | $6.37(-3.45%) | 10 Day Moving Average | $6.58(-6.53%) | 20 Day Moving Average | $6.65(-7.52%) | To recent high | -30.1% | To recent low | 0.1% | Market Cap | $509m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |